# Catheter-directed Sclerotherapy Versus Surgical Resecction: Randomized Controlled Trial Comparing Ovarian Function and Therapeutic Efficacy After Treatment of Ovarian Endometrioma

> **NCT05279209** · NA · UNKNOWN · sponsor: **Yonsei University** · enrollment: 98 (estimated)

## Conditions studied

- Ovarian Endometrioma

## Interventions

- **PROCEDURE:** catheter-directed sclerotherapy
- **PROCEDURE:** surgical resection

## Key facts

- **NCT ID:** NCT05279209
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-18
- **Primary completion:** 2022-12-17
- **Final completion:** 2023-12-17
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2022-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05279209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05279209, "Catheter-directed Sclerotherapy Versus Surgical Resecction: Randomized Controlled Trial Comparing Ovarian Function and Therapeutic Efficacy After Treatment of Ovarian Endometrioma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05279209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
